Professor Sean Tu Cited in Stat News Article On Pharmaceutical Patents
Professor Sean Tu was interviewed for and cited in a Stat News article about a patent infringement lawsuit filed by Regeneron Pharmaceuticals against Amgen. Regeneron is arguing that Amgen is infringing on its patent for its drug, Eylea, an injectable used for treating eye diseases such as wet age-related macular degeneration, by creating a biosimilar…